A Decentralized Clinical Trial (DCT) is a study model that leverages technology and remote processes to conduct research outside traditional clinical settings. DCTs allow participants to engage in trials from their homes or local healthcare facilities, reducing the need for frequent visits to centralized study sites.
This approach utilizes digital health technologies, telemedicine, and home health care services to collect data and monitor participants. DCTs aim to improve patient recruitment and retention by offering greater convenience and accessibility, particularly for individuals with mobility issues or those living in remote areas.
Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by addressing key challenges in traditional trial methodologies. They offer potential solutions to issues such as slow patient recruitment, high dropout rates, and limited diversity in study populations, which have long hindered the efficiency and representativeness of clinical studies.
The importance of DCTs has been further highlighted by global events like the COVID-19 pandemic, which necessitated alternative approaches to conducting research. By embracing DCTs, the clinical research industry can enhance patient-centricity, improve data quality through continuous monitoring, and potentially accelerate the drug development process, leading to faster delivery of new treatments to patients.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant